Studies tumor and blood samples to understand ovarian cancer drug resistance
Collects tumor, fluid and blood samples from people with ovarian cancer to study treatment resistance.
Plain-language title generated from the registry record
Registry title: Systems Oncology Approach to Optimize Ovarian Cancer Treatment
Key facts
- Where
- Helsinki, FinlandSee the site
Where in Finland
- Helsinki University and Helsinki University HospitalHelsinki, FinlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of Helsinki
- Trial code
- NCT06117384
- Record updated
- 7 November 2023
- Original description
The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.Read full original descriptionShow less
Systems Oncology Approach to Optimize Ovarian Cancer Treatment
The overall aim is to identify effective therapeutic strategies to ovarian cancer (OC) using serial tumor, ascites and blood samples, and carry out state-of-the-art sequencing approaches, functional assays and associated bioinformatics to understand mechanisms behind chemoresistance in OC and identify new treatment options for OC patients. In this observational trial, we will systematically collect, analyze and interpret functional, molecular and clinical data from real-world ovarian cancer patients.
Inclusion: Patients diagnosed with ovarian cancer; Available tumor tissue/blood samples.
Exclusion: Inability to consent to the study.